MDGL- Madrigal Pharmaceuticals, Inc.

Name: Madrigal Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Madrigal Pharmaceuticals, Inc. (MDGL) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 95 sells. MDGL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Taub Rebecca	452.2K	$241.87M	-
Dir	Friedman Paul A	205.0K	$109.65M	-
Dir	Baker Bros. Advisors LP	200.0K	$106.99M	-
CEO	Sibold William John	150.1K	$80.27M	-
Dir	Levy Richard S	29.7K	$15.88M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 6, 2026	Taub Rebecca	Director	Sell	491	$431.94	$212,082.54	-0.1%	-	-
Mar 6, 2026	Huntsman Carole	Chief Commercial Officer	Sell	419	$431.94	$180,982.86	-3.2%	-	-
Jan 9, 2026	Taub Rebecca	Director	Sale+OE	18,410	$522.40	$9,617,312.08	-0.1%	+2.0%	-
Jan 9, 2026	Taub Rebecca	Director	Sale+OE	240	$550.33	$132,080.00	-	+2.0%	-
Jan 9, 2026	Friedman Paul A	Director	Sale+OE	280	$551.24	$154,347.59	-0.1%	+2.0%	-
Jan 9, 2026	Friedman Paul A	Director	Sale+OE	24,520	$522.39	$12,808,956.93	-0.4%	+2.0%	-
Dec 10, 2025	Taub Rebecca	Director	Sale+OE	18,650	$552.15	$10,297,572.90	-0.4%	-21.7%	-
Dec 10, 2025	Friedman Paul A	Director	Sale+OE	24,800	$552.18	$13,694,157.83	-1.4%	-21.7%	-
Dec 4, 2025	Sibold William John	President And CEO	Sale+OE	2,400	$575.34	$1,380,816.00	-1.6%	-25.8%	-
Dec 2, 2025	Dier Mardi70	EVP And CFO	Sale+OE	4,173	$578.34	$2,413,416.41	-2.3%	-24.0%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC